电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

HLAG 抗体 (C-Term)

This anti-HLAG antibody is a 小鼠 单克隆 antibody detecting HLAG in WB, FACS, IHC (fro), IHC (p), IF, EIA 和 ELISA (Capture). Suitable for 人.
产品编号 ABIN238372
发货至: 中国
Contact our Customer Service for availability and price in your country. Contact Info

Our Local Distributor

中国
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
4A Biotech Co.,Ltd.
Tel +86 (0512) 65829739 传真 +86 (010) 6788 5057

Quick Overview for HLAG 抗体 (C-Term) (ABIN238372)

抗原

See all HLAG 抗体
HLAG (HLA Class I Histocompatibility Antigen, alpha Chain G (HLAG))

适用

  • 155
  • 7
  • 3
  • 1
  • 1
  • 1
  • 1

宿主

  • 107
  • 52
  • 3
  • 1
  • 1
小鼠

克隆类型

  • 111
  • 53
单克隆

标记

  • 106
  • 17
  • 15
  • 10
  • 6
  • 4
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This HLAG antibody is un-conjugated

应用范围

  • 62
  • 57
  • 53
  • 46
  • 25
  • 22
  • 13
  • 9
  • 9
  • 6
  • 6
  • 5
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Flow Cytometry (FACS), Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunofluorescence (IF), Enzyme Immunoassay (EIA), ELISA (Capture)

克隆位点

5A6G7
  • 抗原表位

    • 11
    • 8
    • 5
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    C-Term

    特异性

    The antibody 5A6G7 allows to discriminate between soluble HLA-G protein yielded by shedding from membrane-bound HLA-G forms that do not contain the intron 4-encoded epitope and soluble HLA-G5/HLA-G6 produced from intron 4-retaining alternatively spliced mRNAs. HLA-G belongs to the MHC Class I molecules (MHC Class Ib, nonclassical) and it is expressed on the surface of trophoblast cells.

    交叉反应 (详细)

    Species reactivity (tested):Human

    产品特性

    Synonyms: HLA-6.0, HLAG, MHC class I antigen G, HLA class I histocompatibility antigen

    纯化方法

    Protein A chromatography

    免疫原

    C-terminal amino acid sequence (22-mer) of soluble HLA-G5 and HLA-G6 proteins coupledto ovalbumin.

    亚型

    IgG1
  • 应用备注

    Western Blotting (Reducing Conditions): 12 % AA SDS-PAGE. Positive Control: JEG-3 cell lysate. Flow Cytometry. Immunohistochemistry on Paraffin and Frozen Sections: 10-20 μg/mL. Positive tissue: placenta tissue. Immunocytochemistry. ELISA: The antibody 5A6G7 has been tested as the capture antibody in a sandwich ELISAfor analysis of soluble HLA-G in combination with antibody ABIN238525. Positive Control: HeLa/HLA-G5 transfectants cell lysate. HeLa/HLA-G5 cell supernatant. Negative Control: HeLa cell lysate.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.

    限制

    仅限研究用
  • 浓度

    1.0 mg/mL

    缓冲液

    PBS, pH 7.4 with 15 mM Sodium Azide as preservative

    储存液

    Sodium azide

    注意事项

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    储存条件

    4 °C/-20 °C

    储存方法

    Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer. Avoid repeated freezing and thawing.
    Shelf life: one year from despatch.

    有效期

    12 months
  • 抗原

    HLAG (HLA Class I Histocompatibility Antigen, alpha Chain G (HLAG))

    别名

    HLA Class I alpha G / HLA-G

    背景

    HLA G belongs to the HLA class I heavy chain paralogues. It is a heterodimer consisting of a heavy chain (with a1, a2, a3 domains) and a light chain (beta 2 microglobulin). Alternate splicing provides both soluble and membrane bound forms of HLA G, with two soluble isoforms and four membrane bound isoforms. HLA G may be part of the fetal protection system and is expressed on fetal derived placental cells.Synonyms: HLA class I histocompatibility antigen, HLA-6.0, HLAG, MHC class I antigen G

    基因ID

    3135

    UniProt

    P17693

    途径

    Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints, Human Leukocyte Antigen (HLA) in Adaptive Immune Response
You are here: